Cargando…

HNRNPC Promotes Proliferation, Metastasis and Predicts Prognosis in Prostate Cancer

INTRODUCTION: The incidence of prostate cancer remains high worldwide, while exploring new therapeutic targets for prostate cancer is essential. Heterogeneous nuclear ribonucleoproteins have been proved to regulate tumorigeneses in various cancers. This study aimed to explore the role of HNRNPC in p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Shiyu, Xu, Guoxiong, Chao, Fan, Zhang, Cong, Han, Dunsheng, Chen, Gang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464311/ https://www.ncbi.nlm.nih.gov/pubmed/34584453 http://dx.doi.org/10.2147/CMAR.S330713

Ejemplares similares

The Emerging Role of Circular RNAs in Prostate Cancer: A Systematic Review
por: Chao, Fan, et al.
Publicado: (2021)

Alpha-L-Fucosidase Has Diagnostic Value in Prostate Cancer With “Gray-Zone PSA” and Inhibits Cancer Progression via Regulating Glycosylation
por: Zhang, Cong, et al.
Publicado: (2021)

Cell-free DNA as a Promising Diagnostic Biomarker in Prostate Cancer: A Systematic Review and Meta-Analysis
por: Zhang, Cong, et al.
Publicado: (2022)

Deep Learning-Based Multi-Omics Integration Robustly Predicts Relapse in Prostate Cancer
por: Wei, Ziwei, et al.
Publicado: (2022)

HNRNPC suppresses tumor immune microenvironment by activating Treg cells promoting the progression of prostate cancer
por: Cheng, Yifei, et al.
Publicado: (2023)

HNRNPC, a predictor of prognosis and immunotherapy response based on bioinformatics analysis, is related to proliferation and invasion of NSCLC cells
por: Gu, Zhuoyu, et al.
Publicado: (2022)

Circular RNA circSMARCA5 is a prognostic biomarker in patients with malignant tumor: a meta-analysis
por: Chao, Fan, et al.
Publicado: (2021)

hnRNPC Promotes Malignancy in Pancreatic Cancer through Stabilization of IQGAP3
por: Yang, Nannan, et al.
Publicado: (2022)

M6A RNA Methylation Regulator HNRNPC Contributes to Tumorigenesis and Predicts Prognosis in Glioblastoma Multiforme
por: Wang, Li-chong, et al.
Publicado: (2020)

Long non-coding RNA DDX11-AS1 promotes the proliferation and migration of glioma cells by combining with HNRNPC
por: Xiang, Zijin, et al.
Publicado: (2022)

LncRNA CEBPA-DT promotes liver cancer metastasis through DDR2/β-catenin activation via interacting with hnRNPC
por: Cai, Yunshi, et al.
Publicado: (2022)

hnRNPC regulates cancer-specific alternative cleavage and polyadenylation profiles
por: Fischl, Harry, et al.
Publicado: (2019)

Function of HNRNPC in breast cancer cells by controlling the dsRNA‐induced interferon response
por: Wu, Yusheng, et al.
Publicado: (2018)

USP39 promotes hepatocellular carcinogenesis through regulating alternative splicing in cooperation with SRSF6/HNRNPC
por: Zheng, Jingyi, et al.
Publicado: (2023)

HNRNPC downregulation inhibits IL‐6/STAT3‐mediated HCC metastasis by decreasing HIF1A expression
por: Liu, Danfei, et al.
Publicado: (2022)

Long noncoding RNA LINC01296 is associated with poor prognosis in prostate cancer and promotes cancer-cell proliferation and metastasis
por: Wu, Jie, et al.
Publicado: (2017)

LINC00924-induced fatty acid metabolic reprogramming facilitates gastric cancer peritoneal metastasis via hnRNPC-regulated alternative splicing of Mnk2
por: He, Qiuming, et al.
Publicado: (2022)

Novel circular RNA circSOBP governs amoeboid migration through the regulation of the miR‐141‐3p/MYPT1/p‐MLC2 axis in prostate cancer
por: Chao, Fan, et al.
Publicado: (2021)

Overexpression of MCM10 promotes cell proliferation and predicts poor prognosis in prostate cancer
por: Cui, Feilun, et al.
Publicado: (2018)

hnRNPC induces isoform shifts in miR-21-5p leading to cancer development
por: Park, Seokju, et al.
Publicado: (2022)

Influence of N6-Methyladenosine Modification Gene HNRNPC on Cell Phenotype in Parkinson's Disease
por: Quan, Wei, et al.
Publicado: (2021)

SALL4 correlates with proliferation, metastasis, and poor prognosis in prostate cancer by affecting MAPK pathway
por: Zhou, Jie, et al.
Publicado: (2023)

Overexpression of shugoshin1 predicts a poor prognosis for prostate cancer and promotes metastasis by affecting epithelial–mesenchymal transition
por: Mu, Jiagui, et al.
Publicado: (2019)

Inhibition of GLS suppresses proliferation and promotes apoptosis in prostate cancer
por: Zhang, Junfeng, et al.
Publicado: (2019)

Overexpression of hnRNPC2 induces multinucleation by repression of Aurora B in hepatocellular carcinoma cells
por: SUN, DA-QUAN, et al.
Publicado: (2013)

High expression of TRIM24 predicts worse prognosis and promotes proliferation and metastasis of epithelial ovarian cancer
por: Zhang, Liwei, et al.
Publicado: (2022)

lncRNA CYTOR promotes aberrant glycolysis and mitochondrial respiration via HNRNPC-mediated ZEB1 stabilization in oral squamous cell carcinoma
por: Zhu, Weiwen, et al.
Publicado: (2022)

HNRNPC promotes collagen fiber alignment and immune evasion in breast cancer via activation of the VIRMA-mediated TFAP2A/DDR1 axis
por: Lian, Bin, et al.
Publicado: (2023)

Circular RNA circ‐FIRRE interacts with HNRNPC to promote esophageal squamous cell carcinoma progression by stabilizing GLI2 mRNA
por: Zhou, Yongjia, et al.
Publicado: (2023)

MiR-744-5p inducing cell death by directly targeting HNRNPC and NFIX in ovarian cancer cells
por: Kleemann, Michael, et al.
Publicado: (2018)

M6A-related bioinformatics analysis reveals that HNRNPC facilitates progression of OSCC via EMT
por: Huang, Guang-Zhao, et al.
Publicado: (2020)

Polo-like kinase 3 is associated with poor prognosis and regulates proliferation and metastasis in prostate cancer
por: Lin, Chunhao, et al.
Publicado: (2019)

The homogeneous and heterogeneous risk factors for the morbidity and prognosis of bone metastasis in patients with prostate cancer
por: Guo, Xu, et al.
Publicado: (2018)

HNRNPC regulates RhoA to induce DNA damage repair and cancer‐associated fibroblast activation causing radiation resistance in pancreatic cancer
por: Xia, Ning, et al.
Publicado: (2022)

FBXW2 inhibits prostate cancer proliferation and metastasis via promoting EGFR ubiquitylation and degradation
por: Zhou, Tao, et al.
Publicado: (2022)

ADAR and hnRNPC deficiency synergize in activating endogenous dsRNA-induced type I IFN responses
por: Herzner, Anna-Maria, et al.
Publicado: (2021)

Case report: Identification of a novel HNRNPC::RARG fusion in acute promyelocytic leukemia lacking RARA rearrangement
por: Ding, Wenjing, et al.
Publicado: (2023)

SHOX2 promotes prostate cancer proliferation and metastasis through disruption of the Hippo-YAP pathway
por: Yang, Wenjie, et al.
Publicado: (2023)

Increased AURKA promotes cell proliferation and predicts poor prognosis in bladder cancer
por: Guo, Mengjie, et al.
Publicado: (2018)

Sema3C promotes hepatic metastasis and predicts poor prognosis in gastric adenocarcinoma
por: Li, Maoran, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_os344n30l11gurai42f4mqv2na